Heart failure and COPD: Partners in crime?

Respirology

Volumn 15, Issue 6, 2010, Pages 895-901

  Hannink, Jorien D C ^a   Van Helvoort, Hanneke A C ^a   Dekhuijzen, P N Richard ^a   Heijdra, Yvonne F ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

chronic obstructive pulmonary disease; epidemiology; heart failure; prevalence

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; DIURETIC AGENT; NATRIURETIC FACTOR; VASODILATOR AGENT;

ASTHMA; BRONCHIECTASIS; BRONCHODILATATION; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; COR PULMONALE; CORONARY ARTERY DISEASE; COUGHING; CYSTIC FIBROSIS; DIASTOLIC DYSFUNCTION; DISEASE EXACERBATION; DYSPNEA; ECHOCARDIOGRAPHY; EMPHYSEMA; FORCED EXPIRATORY VOLUME; HEART CATHETERIZATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FILLING PRESSURE; HEART SCINTISCANNING; HOSPITALIZATION; HUMAN; HYPERTENSION; LUNG FIBROSIS; LUNG FUNCTION TEST; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULMONARY ARTERY OCCLUSION PRESSURE; PULMONARY HYPERTENSION; REVIEW; SENSITIVITY AND SPECIFICITY; SPIROMETRY; SPUTUM; SYSTOLIC DYSFUNCTION;

COMORBIDITY; FEMALE; HEART FAILURE; HUMANS; MALE; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 77954934934     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2010.01776.x     Document Type: Review

References (71)

1. Mannino DM, Homa DM, Akinbami LJ et al. Chronic obstructive pulmonary disease surveillance - United States, 1971-2000. Respir. Care 2002 47 : 1184 1199.
2. Mosterd A, Hoes AW, de Bruyne MC et al. Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. Eur. Heart J. 1999 20 : 447 455.
3. Rutten FH, Cramer MJ, Grobbee DE et al. Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur. Heart J. 2005 26 : 1887 1894.
4. Le Jemtel TH, Padeletti M, Jelic S. Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure. J. Am. Coll. Cardiol. 2007 49 : 171 180.
5. Light RW, George RB. Serial pulmonary function in patients with acute heart failure. Arch. Intern. Med. 1983 143 : 429 433.
6. Salpeter SS, Ormiston T, Salpeter E et al. Cardioselective beta-blockers for chronic obstructive pulmonary disease. Cochrane Database Syst: Rev. 2002 2, CD003566.
7. Salpeter SR, Ormiston TM, Salpeter EE. Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis. Chest 2004 125 : 2309 2321.
8. Celli BR, Macnee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur. Respir. J. 2004 23 : 932 946.
9. Pauwels RA, Buist AS, Calverley PM et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am. J. Respir. Crit. Care Med. 2001 163 : 1256 1276.
10. Snider GL. Nosology for our day: its application to chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2003 167 : 678 683.
11. Halbert RJ, Natoli JL, Gano A et al. Global burden of COPD: systematic review and meta-analysis. Eur. Respir. J. 2006 28 : 523 532.
12. Schermer TR, Smeele IJ, Thoonen BP et al. Current clinical guideline definitions of airflow obstruction and COPD overdiagnosis in primary care. Eur. Respir. J. 2008 32 : 945 952.
13. Albers M, Schermer T, Molema J et al. Do family physicians' records fit guideline diagnosed COPD? Fam. Pract. 2009 26 : 81 7.
14. Damarla M, Celli BR, Mullerova HX et al. Discrepancy in the use of confirmatory tests in patients hospitalized with the diagnosis of chronic obstructive pulmonary disease or congestive heart failure. Respir. Care 2006 51 : 1120 1124.
15. Buist AS, McBurnie MA, Vollmer WM et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007 370 : 741 750.
16. Menezes AM, Perez-Padilla R, Jardim JR et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005 366 : 1875 1881.
17. Hunt SA, Abraham WT, Chin MH et al. 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration with the International Society for Heart and Lung Transplantation. J. Am. Coll. Cardiol. 2009 53 : e1 90.
18. Dickstein K, Cohen-Solal A, Filippatos G et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur. Heart J. 2008 29 : 2388 2442.
19. Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart 2007 93 : 1137 1146.
20. Hogg K, Swedberg K, McMurray J. Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. J. Am. Coll. Cardiol. 2004 43 : 317 327.
21. Paulus WJ, Tschope C, Sanderson JE et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur. Heart J. 2007 28 : 2539 2550.
22. McDonagh TA, Cunningham AD, Morrison CE et al. Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population. Heart 2001 86 : 21 6.
23. Redfield MM, Jacobsen SJ, Burnett JC et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003 289 : 194 202.
24. How to diagnose diastolic heart failure. European Study Group on Diastolic Heart Failure. Eur. Heart J. 1998 19 : 990 1003.
25. McCullough PA, Hollander JE, Nowak RM et al. Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department. Acad. Emerg. Med. 2003 10 : 198 204.
26. Abroug F, Ouanes-Besbes L, Nciri N et al. Association of left-heart dysfunction with severe exacerbation of chronic obstructive pulmonary disease: diagnostic performance of cardiac biomarkers. Am. J. Respir. Crit. Care Med. 2006 174 : 990 996.
27. Curkendall SM, DeLuise C, Jones JK et al. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann. Epidemiol. 2006 16 : 63 70.
28. Holguin F, Folch E, Redd SC et al. Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. Chest 2005 128 : 2005 2011.
29. Huiart L, Ernst P, Suissa S. Cardiovascular morbidity and mortality in COPD. Chest 2005 128 : 2640 2646.
30. Rutten FH, Cramer MJ, Lammers JW et al. Heart failure and chronic obstructive pulmonary disease: an ignored combination? Eur. J. Heart Fail. 2006 8 : 706 711.
31. Kline LE, Crawford MH, MacDonald WJ et al. Noninvasive assessment of left ventricular performance in patients with chronic obstructive pulmonary disease. Chest 1977 72 : 558 564.
32. Jezek V. Left ventricular volumetry and function in chronic cor pulmonale. Cor Vasa 1981 23 : 94 103.
33. Louridas G, Patakas D, Stavropoulos C. Left ventricular function in patients with chronic obstructive pulmonary disease. Cardiology 1981 67 : 73 80.
34. Rocha NN, Stelmach R, Cukier A et al. Assessment of the ventricular function of patients with advanced chronic obstructive pulmonary disease by using magnetic resonance imaging. Arq. Bras. Cardiol. 2004 83 : 326 331.
35. Scharf SM, Iqbal M, Keller C et al. Hemodynamic characterization of patients with severe emphysema. Am. J. Respir. Crit. Care Med. 2002 166 : 314 322.
36. Seibold H, Roth U, Lippert R et al. Left heart function in chronic obstructive lung disease. Klin. Wochenschr. 1986 64 : 433 441.
37. Yilmaz R, Gencer M, Ceylan E et al. Impact of chronic obstructive pulmonary disease with pulmonary hypertension on both left ventricular systolic and diastolic performance. J. Am. Soc. Echocardiogr. 2005 18 : 873 881.
38. Christianson LC, Shah A, Fisher VJ. Quantitative left ventricular cineangiography in patients with chronic obstructive pulmonary disease. Am. J. Med. 1979 66 : 399 404.
39. Boussuges A, Pinet C, Molenat F et al. Left atrial and ventricular filling in chronic obstructive pulmonary disease. An echocardiographic and Doppler study. Am. J. Respir. Crit. Care Med. 2000 162 : 670 675.
40. Louie EK, Rich S, Levitsky S et al. Doppler echocardiographic demonstration of the differential effects of right ventricular pressure and volume overload on left ventricular geometry and filling. J. Am. Coll. Cardiol. 1992 19 : 84 90.
41. Funk GC, Lang I, Schenk P et al. Left ventricular diastolic dysfunction in patients with COPD in the presence and absence of elevated pulmonary arterial pressure. Chest 2008 133 : 1354 1359.
42. Schena M, Clini E, Errera D et al. Echo-Doppler evaluation of left ventricular impairment in chronic cor pulmonale. Chest 1996 109 : 1446 1451.
43. Incalzi RA, Pistelli R, Fuso L et al. Cardiac arrhythmias and left ventricular function in respiratory failure from chronic obstructive pulmonary disease. Chest 1990 97 : 1092 1097.
44. Jardin F, Gueret P, Dubourg O et al. Two-dimensional echocardiographic evaluation of right ventricular size and contractility in acute respiratory failure. Crit. Care Med. 1985 13 : 952 956.
45. Unger K, Shaw D, Karliner JS et al. Evaluation of left ventricular performance in acutely ill patients with chronic obstructive lung disease. Chest 1975 68 : 135 142.
46. Mascarenhas J, Lourenco P, Lopes R et al. Chronic obstructive pulmonary disease in heart failure. Prevalence, therapeutic and prognostic implications. Am. Heart J. 2008 155 : 521 525.
47. Hawkins NM, Petrie MC, Jhund PS et al. Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. Eur. J. Heart Fail. 2009 11 : 130 139.
48. Petermann W, Barth J, Entzian P. Heart failure and airway obstruction. Int. J. Cardiol. 1987 17 : 207 209.
49. Duguet A, Tantucci C, Lozinguez O et al. Expiratory flow limitation as a determinant of orthopnea in acute left heart failure. J. Am. Coll. Cardiol. 2000 35 : 690 700.
50. Boni E, Bezzi M, Carminati L et al. Expiratory flow limitation is associated with orthopnea and reversed by vasodilators and diuretics in left heart failure. Chest 2005 128 : 1050 1057.
51. Evans SA, Kinnear WJ, Watson L et al. Breathlessness and exercise capacity in heart failure: the role of bronchial obstruction and responsiveness. Int. J. Cardiol. 1996 57 : 233 240.
52. Kindman LA, Vagelos RH, Willson K et al. Abnormalities of pulmonary function in patients with congestive heart failure, and reversal with ipratropium bromide. Am. J. Cardiol. 1994 73 : 258 262.
53. Kurzawa R, Baron T, Grodzicki T. Pulmonary function test abnormalities in the elderly with systolic heart failure. Kardiol. Pol. 2007 65 : 875 880.
54. Sin DD, Man SF. Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc. Am. Thorac. Soc. 2005 2 : 8 11.
55. Mannino DM, Thorn D, Swensen A et al. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur. Respir. J. 2008 32 : 962 969.
56. Gan WQ, Man SF, Senthilselvan A et al. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004 59 : 574 580.
57. Ridker PM. High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention. Am. J. Cardiol. 2003 92 : 17K 22K.
58. Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003 107 : 1514 1519.
59. Iwamoto H, Yokoyama A, Kitahara Y et al. Airflow limitation in smokers is associated with subclinical atherosclerosis. Am. J. Respir. Crit. Care Med. 2009 179 : 35 40.
60. Sabit R, Bolton CE, Edwards PH et al. Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2007 175 : 1259 1265.
61. Zureik M, Benetos A, Neukirch C et al. Reduced pulmonary function is associated with central arterial stiffness in men. Am. J. Respir. Crit. Care Med. 2001 164 : 2181 2185.
62. Eickhoff P, Valipour A, Kiss D et al. Determinants of systemic vascular function in patients with stable chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2008 178 : 1211 1218.
63. Mills NL, Miller JJ, Anand A et al. Increased arterial stiffness in patients with chronic obstructive pulmonary disease; a mechanism for increased cardiovascular risk. Thorax 2007 63 : 306 311.
64. McAllister DA, Maclay JD, Mills NL et al. Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2007 176 : 1208 1214.
65. Chaouat A, Naeije R, Weitzenblum E. Pulmonary hypertension in COPD. Eur. Respir. J. 2008 32 : 1371 1385.
66. Weitzenblum E. Chronic cor pulmonale. Heart 2003 89 : 225 230.
67. Rutten FH, Cramer MJ, Zuithoff NP et al. Comparison of B-type natriuretic peptide assays for identifying heart failure in stable elderly patients with a clinical diagnosis of chronic obstructive pulmonary disease. Eur. J. Heart Fail. 2007 9 : 651 659.
68. Maisel AS, Krishnaswamy P, Nowak RM et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N. Engl. J. Med. 2002 347 : 161 167.
69. Januzzi JL Jr., Camargo CA, Anwaruddin S et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am. J. Cardiol. 2005 95 : 948 954.
70. Tung RH, Camargo CA Jr., Krauser D et al. Amino-terminal pro-brain natriuretic peptide for the diagnosis of acute heart failure in patients with previous obstructive airway disease. Ann. Emerg. Med. 2006 48 : 66 74.
71. Maisel A. The coming of age of natriuretic peptides: the emperor does have clothes! J. Am. Coll. Cardiol. 2006 47 : 61 4.